Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 312

Results For "US"

8392 News Found

Sandoz launches renewable energy partnership
Sustainability | August 12, 2025

Sandoz launches renewable energy partnership

The agreement complements other PPAs for Sandoz production sites globally


Gland Pharma gets approval for Norepinephrine Bitartrate in 5% Dextrose injection bags
Drug Approval | August 12, 2025

Gland Pharma gets approval for Norepinephrine Bitartrate in 5% Dextrose injection bags

The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Norepinephrine Bitartratein 5% Dextrose of Baxter Healthcare Corp


Lupin partners with Sadoz to commercialise Ranibizumab biosimilar
News | August 12, 2025

Lupin partners with Sadoz to commercialise Ranibizumab biosimilar

Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A


Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad
News | August 12, 2025

Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad

This strategic investment strengthens Cohance's integrated oligonucleotide platform


Dr. Jitendra Singh inaugurates animal stem cell BioBank and laboratory at NIAB, Hyderabad
Biotech | August 11, 2025

Dr. Jitendra Singh inaugurates animal stem cell BioBank and laboratory at NIAB, Hyderabad

Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance


LAXAI Life Sciences appoints Sripathy Venkatraman as CEO
People | August 11, 2025

LAXAI Life Sciences appoints Sripathy Venkatraman as CEO

Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives


Aurobindo Pharma Q1 FY26 PAT slips 10% YoY to Rs. 824 Cr
News | August 10, 2025

Aurobindo Pharma Q1 FY26 PAT slips 10% YoY to Rs. 824 Cr

Aurobindo Pharma’s US formulations revenue slipped 1.9% on a year-on-year basis to Rs. 3,488 crore


Wockhardt reports Q1 FY26 loss at Rs. 108 Cr
News | August 10, 2025

Wockhardt reports Q1 FY26 loss at Rs. 108 Cr

Consolidated revenue from operations in the quarter was marginally down at Rs 738 crore a


Akums reports Q1 FY26 PAT at Rs. 65 Cr
News | August 09, 2025

Akums reports Q1 FY26 PAT at Rs. 65 Cr

During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals